Top ten late-breaking data to look for at ASCO 2024
New melanoma treatments, blockbuster lung cancer data, and resurrected blood cancer drugs feature at the conference.
New melanoma treatments, blockbuster lung cancer data, and resurrected blood cancer drugs feature at the conference.
The cost saving programme is expected to save the company approximately $1.5bn by 2027.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Sanofi enters partnership to enhance drug development using AI
UK clinical trials industry tackles recent changes in the sector
Rakovina expands collaborations to leverage AI platform
Biotechs must prioritise ethics to deter GenAI “bad actors”